RecruitingNot ApplicableNCT03527420

DNA Methylation and Vascular Function

DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight Loss


Sponsor

University of Illinois at Chicago

Enrollment

80 participants

Start Date

Oct 11, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria4

  • BMI ≥ 35 kg/m2
  • Between ages 18-50 years
  • Not pregnant
  • Approved for a bariatric surgery

Exclusion Criteria4

  • To avoid confounding from other inflammatory conditions individuals with current cancer, heart, kidney or liver disease, gallbladder disease or acute or chronic inflammatory diseases (including rheumatoid arthritis, lupus and other autoimmune diseases and genetic diseases) will be excluded
  • Pregnant women will be excluded, as they will not be eligible for bariatric surgery
  • Current smokers
  • Currently abusing alcohol or drugs

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise training

Twelve weeks of aerobic exercise training


Locations(1)

University of Illinois at Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03527420


Related Trials